Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Zetia was produced by Merck & Co. and Bayer.

US pharma turning the corner

S-P's cholesterol treatment, Vytorin, which combines its drug Zetia with Merck's Zocor, is not counted in the firm's sales because of accounting rules; the two companies share

Merck working on recovery plan as sales dip

UK). Bright spots for Merck were sales of asthma drug Singulair, which saw an 11 per cent rise to $692m and anti-cholesterol drugs Zetia and Vytorin, which saw combined sales

Rocky Road

70 per cent when used together with Zetia, a drug made by Schering-Plough. ... Schering-Plough also sells Zetia in combination with Merck's Zocor for cholesterol sufferers.

Schering-Plough to cut jobs

Schering-Plough, like other companies in the sector, is under intense financial pressure, particularly in the US, not least because of confusion in the marketplace about cholesterol-lowering treatments Zetia and ... He made particular reference to the

Merck surprises with Q2 FY07 profits increase

percent over the same period in 2006. Zetia (ezetimibe) and Vytorin (ezetimibe plus simvastatin), cholesterol drugs, co-marketed with Schering-Plough, were also big earners. ... Global sales of Zetia reached USD578m, an increase of 21 per cent compared

[ Previous 5 results ] 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

BRIC markets
BRIC markets
Why these countries offer an opportunity for pharma despite a slowdown...
Obstetrics Virtual Journal Club: An Impetus Digital Customer Success Story
Our online solutions are not just for advisory boards - find out how one client leveraged the Impetus InSite Platform® for a virtual journal club....
Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...